成人中线胶质瘤中H3 K27M突变的发病率与临床病理特征
本研究筛查2007至2017年850例胶质瘤,163例MRI显示中线部位,123例有足够组织进行免疫组化。H3 K27M突变见于18/123例(15%),除一例外均为WHO III或IV级。H3 K27M突变组中位生存17.6个月,高于高级别野生型组的7.7个月(p=0.03)。
要点
- 成人中线胶质瘤中H3 K27M突变率为15%(18/123)。
- H3 K27M突变肿瘤绝大多数为WHO III或IV级。
- H3 K27M突变组中位生存17.6个月 vs 高级别野生型组7.7个月(p=0.03)。
核心结论
- H3 K27M突变在成人中线胶质瘤中常见,可出现在所有中线部位;生存比较提示突变存在时生存可能相似或有所改善。
研究设计与样本
- 连续筛查2007至2017年850例胶质瘤,163例MRI诊断为中线胶质瘤,123例(75%)有足够FFPE组织进行H3 K27M、IDH1和ATRX免疫组化。
主要发现
- 123例中18例(15%)检出H3 K27M突变。
- H3 K27M突变肿瘤除一例外均为WHO III或IV级,非突变肿瘤涵盖所有四个级别。
- H3 K27M突变肿瘤最常见中线部位为中脑(2/3;67%)、脑桥(4/11;36%)和小脑(6/24;25%)。
- 与H3 K27M野生型相比,诊断年龄、性别、肿瘤级别、MRI强化、切除范围或接受治疗无差异。
- H3 K27M突变组(n=18)中位生存17.6个月 vs 高级别野生型组(n=74)7.7个月(p=0.03)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: H3 K27 mutations, most commonly in H3F3A, are common in diffuse midline glioma. The exact frequency of these mutations in adults with gliomas in the midline location is unknown. This study was conducted to define the incidence of H3 K27M mutations in this location and to compare clinicopathological features with those of patients who do not harbor this mutation. METHODS: Consecutive glioma cases from 2007 to 2017 were screened for gliomas in the midline location. Immunohistochemistry was performed on all available tissue for mutations of H3 K27M, IDH1, and ARTX. RESULTS: Of 850 gliomas screened, 163 cases had midline glioma on MRI. Sufficient FFPE tissue was available for 123 cases (75%). H3 K27M mutation was identified in 18 of 123 cases (15%). All except one H3 K27M-mutant tumors were WHO grade III or IV on histology, while non-mutant tumors encompassed all four grades. The most common midline locations for H3 K27M-mutated tumors were midbrain (2/3; 67%), pons (4/11; 36%), and cerebellum (6/24; 25%). As compared to H3 K27M-wildtype tumors, there were no differences in age at diagnosis, sex, tumor grade, contrast enhancement on MRI, extent of resection, or treatment received. In this cohort, median survival was longer for patients with H3 K27M-mutated tumors (n = 18; 17.6 months) compared with high-grade wildtype tumors (n = 74; 7.7 months, p = 0.03). CONCLUSIONS: H3 K27M mutations are common in midline gliomas in adults and can present in all midline locations. Survival comparison between H3 K27M-mutant and wildtype midline gliomas suggests that survival may be similar or possibly improved if the mutation is present.
引用
- Schreck KC, Ranjan S, Skorupan N, et al. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol. 2019. PMID: 30864101. doi:10.1007/s11060-019-03134-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。